Skip to content
★ Sign in to follow
RN

Richard N. Levy

Executive
Unigene Laboratories Inc
Total declarations
9
Company
1
▲ Purchases (9 ops.)
€269k
▼ Sales (0 ops.)
—

Latest filing published 22 Dec 2010 for UNIGENE LABORATORIES INC, €28k.

Insider track record

Disclosed buys
9
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
9

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Richard N. Levy: trading record in brief

Richard N. Levy discloses dealings in Unigene Laboratories Inc to SEC (Form 4). We count 9 filings; the first trade dates from 27 August 2010 and the latest from 22 December 2010.

The open-market record is one-sided, with 9 purchases worth €269k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

A typical purchase (the median) is worth €28k.

Most recently, on 22 December 2010, the filings show an open-market purchase worth €28k in Unigene Laboratories Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Richard N. Levy

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total

9 of 9 declarations